Pharma Research Library | Pharma Info Index Research | Innovation | Opportunities |
ABOUT AUTHOR
Patel Chirag J*1, Satyanand Tyagi2, Patel Kanu J3, Patel Tushar4, Patel Harnish K5, Patel Priyanka H6
1Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan, India-302020.
2Founder, President & CEO, Tyagi Pharmacy Association, Chattarpur, New Delhi, India-110074.
3Sharda School of Pharmacy, Pethapur, Gandhinagar, Gujarat, India.
4Aditya Bangalore Institute for Pharmacy Education & Research, Bangalore, Karnataka, India.
5Editor-In-Chief, IJPRBS Journal, Gujarat, India.
6 Director, Research Scholar Hub, Gujarat, India.
Abstract
The last few years have witnessed the discovery, development and, in some cases, large-scale manufacturing and production of novel materials that lie within the nanometer scale. Such novel nanomaterials consist of inorganic or organic matter and in most cases have never been studied in the context of pharmaceuticals. Carbon nanotubes (CNTs) are one of them. These tubes were originally called “buckytubes” but now are better known as carbon nanotubes or CNT for short. These molecules are shaped like a tube; imagine a sheet of graphite (“graphene sheet”) or chicken wire rolled into a tube. Carbon nanotubes are allotropes of carbon with a nanostructure that can have a length-to-diameter ratio greater than 1,000,000. One of the physical properties of carbon nanotubes is that it’s possible to make them only a single atomic layer thick. This means that they can be about 1/50,000th the thickness of a human hair. The small dimensions, strength and the remarkable physical properties of these structures make them a very unique material with a whole range of promising applications. These cylindrical carbon molecules have novel properties that make them potentially useful in many applications in nanotechnology.
Keywords: Nanomedicines, Carbon nanotubes, Buckytubes, Cylindrical
